COR vs HLF
Cencora, Inc. and Herbalife Ltd., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | COR | HLF |
|---|---|---|
| Revenue | $321.3B | $5.0B |
| Net income | $1.6B | $228.3M |
| Gross margin | 3.6% | 77.9% |
| Net margin | 0.5% | 4.5% |
| Return on equity | 144.3% | 364.1% |
| Diluted EPS | $7.96 | $2.20 |
| Dividend / share | $2.20 | $0.30 |
| Payout ratio | 28.1% | 0.0% |
| Free cash flow | $3.2B | $252.9M |
| Equity | $1.5B | $-515.1M |
| Net debt / equity | 2.19× | 3.01× |
| Current ratio | 0.90× | 1.13× |
| Revenue CAGR 5y | 11.1% | −1.9% |
| Profit CAGR 5y | — | −9.3% |
COR bills 63.8× the revenue of HLF, and HLF keeps more of each dollar of revenue as profit (4.5% against 0.5%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
10 years side by side
| Fiscal year | COR | HLF |
|---|---|---|
| FY2025 | $321.3B | $5.0B |
| FY2024 | $294.0B | $5.0B |
| FY2023 | $262.2B | $5.1B |
| FY2022 | $238.6B | $5.2B |
| FY2021 | $214.0B | $5.8B |
| FY2020 | $189.9B | $5.5B |
| FY2019 | $179.6B | $4.9B |
| FY2018 | $167.9B | $4.9B |
| FY2017 | $153.1B | $4.4B |
| FY2016 | $146.8B | $4.5B |
Net income by year
Bottom line
| Fiscal year | COR | HLF |
|---|---|---|
| FY2025 | $1.6B | $228.3M |
| FY2024 | $1.5B | $254.3M |
| FY2023 | $1.7B | $142.2M |
| FY2022 | $1.7B | $321.3M |
| FY2021 | $1.5B | $447.2M |
| FY2020 | $-3.4B | $372.6M |
| FY2019 | $855.4M | $311.0M |
| FY2018 | $1.7B | $296.6M |
| FY2017 | $364.5M | $213.9M |
| FY2016 | $1.4B | $260.0M |
Advertisement
AdSense · Rectangle 336×280